Lisa Koch-Hulle

Lisa Koch-Hulle has more than 25 years of regulatory affairs experience across multiple therapeutic areas and all stages of drug development, with approximately 15 years at the senior management level. Prior to Glycomine, Ms. Koch-Hulle held the position of Vice President of Regulatory Affairs and Clinical Operations at Light Sciences Oncology, and prior to that held the same position at La Jolla Pharmaceutical Company. Ms. Koch-Hulle has also served as a regulatory consultant to the pharmaceutical industry. Ms. Koch-Hulle holds regulatory certifications in US, European, and Global regulatory affairs, and is a former Chair of the RAPS European Certification Committee.